Las Vegas, NV, May 05, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with bi-coastal processing centers, including the 85,000 square foot multipurpose industrial hemp processing facility on 9 acres in Spring Hope, NC, a 55,000 square foot state-of the art local processing center in White City, Oregon, a 500-acre hemp growing Veteran Village Kins Community in Golden Valley, Arizona, two model “Small Family Hemp Farms” in North Carolina and Arizona, a pre-roll blending manufacturing facility in Las Vegas, NV, and a 5,000 square-foot retail store (The King of Hemp Store™) in Kingman, Arizona, has announced the launch of the King of Hemp™ website where Bruce Perlowin’s King of Hemp™ pre-rolls, made from premium, smokable hemp flower, are available for purchase.

Hemp, Inc. CEO Bruce Perlowin’s King of Hemp™ pre-roll line offers high-end products that are an effective and flavorful, smokable alternative to cigarettes and other hemp consumption methods. The newly launched King of Hemp™ pre-rolls are compliant with the 2018 Farm Bill, federal regulations, and regulations in the markets where they are available for purchase. The King of Hemp™ pre-rolls can be purchased individually or in packs of 6. Each pre-roll is 1 gram and does not exceed 0.3% THC.

King of Hemp™ pre-rolls use A and B hemp colas which are derived from Pre-98 OG Bubba Kush, one of the top selling cultivars on the market. The strain, rich soil and climate lend themselves to these colas being among the highest quality buds, positioning them to be some of the best tasting for consumption.

The Company’s new website for its King of Hemp™ line (www.kingofhempusa.com) also has CBD oil tinctures available for purchase. The tinctures are available in two flavors, Natural and Peppermint, and contain full-spectrum hemp oil extracted from the flowers and leaves of hemp plants sustainably sourced from Colorado. They are also compliant with the regulations created by the Colorado Department of Agriculture in regards to industrial hemp. The tinctures contain .3% or less THC and are compliant with the 2018 Farm Bill.

“The King of Hemp™ pre-rolls were well received during our soft launch and have been lauded as one of the best smokes out there. We crafted them with great care -- from concept to the cola, and now with our official launch,” said Hemp, Inc. CEO Bruce Perlowin. “We really wanted to give this product line the time and respect it needed to be brought to market. I’m very excited for hemp enthusiasts, CBD patients and first-time hemp smokers to enjoy the King of Hemp™ pre-roll line.”

According to a report from Research and Markets, the global industrial hemp market is projected to grow from USD 4.6 billion in 2019 to USD 26.6 billion by 2025, recording a CAGR of 34%. Hemp, Inc. identified an increased demand for smokable hemp flower as people seek alternative methods of consumption. The Brightfield Group predicts the smokable hemp flower market is projected to be worth $70.6 million this year, jumping from $11.7 million in 2018.

To see one-minute videos of Hemp, Inc.’s current activities, visit Bruce Perlowin’s personal Facebook page, where he shares daily posts of Hemp, Inc.’s activities around the country.

LAS VEGAS, NV, May 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Hemp, Inc. (OTC PINK: HEMP) announced today that the Company is now able to proceed in a lawsuit against American Hemp Seed Genetics, LLC in the Court of Appeals of North Carolina.

American Hemp Seed Genetic (AHSG) is managed by Jerry Norton of Salem, Oregon. AHSG entered into a contractual agreement with Hemp, Inc.’s wholly owned subsidiary, Industrial Hemp Manufacturing, LLC (IHM), on April 26, 2018.

On October 12, 2018, Hemp, Inc.’s wholly owned subsidiary, Industrial Hemp Manufacturing, LLC (IHM) (Plaintiff), filed a lawsuit against American Hemp Seed Genetic (AHSG) for: Breach of Contract, Breach of Express Warranty, Breach of Implied Warranty of Fitness for a Particular Purpose, Breach of Implied Warranty of Merchantability, Intentional Misrepresentation, Negligent Misrepresentation, Incidental and Consequential Damages, Unfair and Deceptive Trade Practices, and Fraud.

Background on Lawsuit

According to Hemp, Inc. executives, Jerry Norton of AHSG convinced IHM executives that the seeds IHM were to purchase had excellent genetics and were the right seeds for planting in North Carolina’s soil and climate. Thus, IHM agreed to purchase said seeds in order to plant 1,000 acres of hemp for biomass. Norton recommended one pound of seeds per ten acres of land with 100% germination. Norton assured IHM his seeds had a 97% germination rate and to make up for the expected 3% failure rate, he added 3 more pounds of seed for a total of 103 pounds of seed.

Seeds were sent to IHM in North Carolina, per contract. Upon receiving the seeds, IHM did a test for germination and found the seeds had a germination rate in the high teens, much lower than the 97% germination rate that Jerry Norton had assured IHM of. Confounded by the results, IHM sent the seeds out for professional germination testing by experts who were able to get a 24% germination rate; higher than IHM’s first test but still disturbingly lower than what Norton had promised.

Jerry Norton was informed of the results and of the seeds’ failure to germinate properly. At that point, IHM demanded the return of their $70,000 payment with the return of the seeds back to Norton. Norton refused to refund IHM’s payment, did not accept the seeds back, and refused to discuss it further.

As a result of his intransigence, IHM had no choice but to file a lawsuit against AHSG.

Recent Developments

The filing took place on October 12, 2018. AHSG moved to dismiss the lawsuit for lack of personal jurisdiction on December 31, 2018. That motion was denied on February 25, 2019.

AHSG entered an appeal on March 18, 2019. Norton was able to delay the trial for almost one year which prolonged the inevitable.

However, the contract had a clause that was quoted by the appellate judge in denying AHSG’s appeal, “[a]ny dispute arising out of or related to this Agreement shall be venued [sic] in Raleigh, North Carolina.”

On March 3, 2020, AHSG’s appeal was denied which has allowed for IHM to proceed with the lawsuit.

“This was an unfortunate situation that will take more time but we won’t quit until this has been adjudicated. This lawsuit could award IHM $10,000,000 or more for incidental and consequential damages so it’s worth the wait,” said Bruce Perlowin, CEO of Hemp, Inc.

To view documents and reports pertaining to the lawsuit (INDUSTRIAL HEMP MANUFACTURING, LLC, Plaintiff, V. AMERICAN HEMP SEED GENETIC LLC, Defendant) click here. To read the recent article published by “Law360 Hemp Seed Seller (Jerry Norton) Can't Dodge Suit Over $700K Deal”, click here.

Hemp, Inc. is a global leader in the industrial hemp industry with bi-coastal processing centers, including the largest multipurpose industrial hemp processing facility in the western hemisphere. To read more about Hemp, Inc.’s Year-to-Date Milestones, Highlights, and Pending Developments, click here.

To see 1-minute videos of Hemp, Inc.’s current activities, go to Bruce Perlowin’s personal Facebook page where he posts daily on all of Hemp, Inc.’s activities around the country.

WHAT IS HEMP, INC.?

What is Hemp, Inc.? With a deep-rooted social and environmental mission at its core, Hemp, Inc. seeks to build a business constituency for the American small farmer, the American veteran, and other groups experiencing the ever-increasing disparity between tapering income and soaring expenses. As a leader in the industrial hemp industry with ownership of the largest commercial multi-purpose industrial hemp processing facility in North America, Hemp, Inc. believes there can be tangible benefits reaped from adhering to a corporate social responsibility plan.

VANCOUVER, April 30, 2020 /PRNewswire/ - Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the "Company" or "Hollister") – a diversified cannabis branding company with products in over 220 dispensaries throughout California, is pleased to announce that further to the signing of the definitive agreement, as amended (the "SEA"), the Company has now closed its acquisition of AlphaMind Brands Inc. ("AlphaMind"), a growth stage company, that is developing a portfolio of certified legal mushroom based natural health products (the "Transaction").

"We are very pleased to close our acquisition of AlphaMind", shared Carl Saling, Founder and CEO of Hollister. "It is our continual objective to broaden our product scope and Alphamind, with its experienced management team, is a perfect foothold for us in the fast-growing market for medicinal mushrooms and complements our existing cannabis and hemp-based product offering. We are excited to bring another promising brand under the Hollister umbrella, especially in such a fast growing and exciting sector."

"We are very pleased to have closed this transaction", shared Dr. Nikos C. Apostolopoulos, Chief Product & Research Officer of Alphamind Brands. "We are looking forward to working with Hollister to build out our medicinal mushroom based product line and conducting further R&D to develop an exciting IP portfolio surrounding psilocybin based pharmaceutical treatments."

Key Terms of The Transaction

Pursuant to the terms of the SEA, the Company has acquired AlphaMind for consideration of CDN$1,200,000 which is being satisfied by the issuance of 4,200,000 Hollister common shares (the "Payment Shares") on the Closing Date pro rata to the shareholders of AlphaMind and an additional 1,800,000 common shares (the "Earn-Out Shares") to be issued pro rata to the former shareholders of AlphaMind on the earlier of (i) AlphaMind meeting certain milestones (detailed below) or (ii) December 31st, 2021.

The Payment Shares and the Earn-Out Shares will be issued at a deemed value of $0.20 per share;
The Payment Shares are subject to certain voluntary hold periods as follows: 331/3% until May 30th, 2020; an additional 331/3% until June 30th, 2020; and the remaining 331/3% until August 30th, 2020;
The Earn-Out Shares will be issued on the earlier of (i) December 31st, 2020, or (ii) upon AlphaMind's first production run or its first sales of product.


Hollister will not be assuming any long-term debt; no new control position will be created and there is no change in management or the Board of Directors of Hollister in connection with the Transaction.

About AlphaMind Brands Inc.

Alphamind Brands is a Canada and US based growth stage company, that is developing a portfolio of certified legal mushroom based natural health products. It is also actively conducting R&D initiatives, led by Dr. Nikos C. Apostolopoulos, who is exploring psilocybin based pharmaceutical treatments. The company's "ready to ship" product SKU's include Cordyceps, Lion's Mane, Shiitake, Oyster and Reishi Mushroom based: liquid tinctures, concentrated mushroom powder(s), teas, and chocolate.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand's premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the "American Biker".

Website: www.hollistercannabisco.com

ON BEHALF OF THE BOARD

"Carl Saling"

CEO and Director

The CSE does not accept responsibility for the adequacy or accuracy of this release.

The CSE has not in any way passed upon the merits of the Transaction and has neither approved nor disapproved the contents of this press release.

The securities to be issued in connection with the Transaction have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "1933 Act"), or under any state securities laws, and may not be offered or sold, directly or indirectly, or delivered within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the 1933 Act) absent registration or an applicable exemption from the registration requirements. This news release does not constitute an offer to sell or a solicitation to buy such securities in the United States.

VANCOUVER, April 23, 2020 /PRNewswire/ - Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the "Company" or "Hollister") – a diversified cannabis branding company with products in over 220 dispensaries throughout California, is pleased to announce that it has entered into a share exchange agreement dated April 22nd, 2020 among the Company, AlphaMind Brands Inc. ("TargetCo") and the shareholders of TargetCo (the "Definitive Agreement"), pursuant to which, the Company will acquire all of the issued and outstanding shares of TargetCo (the "Proposed Transaction").

Alphamind Brands is a Canada and US based growth stage company, that is developing a portfolio of certified legal mushroom based natural health products. It is also actively conducting R&D initiatives, led by Dr. Nikos C. Apostolopoulos, who is exploring psilocybin based pharmaceutical treatments. The company's "ready to ship" product SKU's include Cordyceps, Lion's Mane, Shiitake, Oyster and Reishi Mushroom based: liquid tinctures, concentrated mushroom powder(s), teas, and chocolate.

"We are very pleased to have completed the next step in consummating this very exciting acquisition", shared Carl Saling, Founder and CEO of Hollister Biosciences, Inc. "It is a fundamental value of our company to improve the overall health and performance of our customers through our high-quality products and the health benefits associated with medicinal mushrooms are tremendous. Not to mention, it is our continual objective to broaden our product scope and Alphamind, with its experienced management team, is a perfect foothold for us in the fast-growing market for medicinal mushrooms and complements our existing cannabis and hemp-based product offering."

"I think we have found a great partner in Hollister", shared Robert Birmingham, CEO of Alphamind Brands. "We have medicinal mushroom based product SKU's ready to ship and R&D is underway to develop an exciting IP portfolio surrounding psilocybin based pharmaceutical treatments. Being under the Hollister umbrella will allow us to access additional markets and leverage their existing manufacturing and distribution infrastructure and will be a fundamental part of the future growth of our business."

The Proposed Transaction

Pursuant to the terms of the Definitive Agreement, Hollister will acquire all of the issued and outstanding securities of TargetCo in consideration for the issuance of 6,000,000 common shares of the Company (the "Payment Shares") pro rata to shareholders of TargetCo at a deemed price of $0.20 per Payment Share upon closing of the Proposed Transaction (the "Closing Date").

The Proposed Transaction remains subject to certain closing conditions including, without limitation, (a) the receipt by Hollister of any necessary corporate and regulatory approval; and (b) each party's representations and warranties in the Definitive Agreement being true and correct in all aspects as of the Closing Date, and each party meeting its terms and conditions and completing its covenants and obligations as contained therein. There can be no guarantees that the Proposed Transaction will be completed as contemplated or at all.

Hollister will not be assuming any long-term debt; no new control position will be created and there is no change in management or the Board of Directors of Hollister in connection with the Proposed Transaction.

In addition, the Company also reports that it will issue 500,000 common shares at a deemed price of $0.12 per share to an arm's length consultant pursuant to a consulting agreement in which services were provided from December 1, 2019 to the date hereof. In addition, the Company will issue 90,400 shares to an arm's length consultant pursuant to a consulting agreement in which services have been rendered since February 17, 2020 (See press release dated February 25th, 2020). All shares issued pursuant to the consulting agreements will be subject to a four month and a day hold period from the date of issuance.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand's premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the "American Biker".

LOL!!~!!
"I Disagree"...."should have read the Docket", "meaningless statement's without fact's".

LAS VEGAS, NV, Feb. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – One World Pharma Inc. (OWPC), is pleased to announce the execution of a Letter of Intent (LOI) between Hemp Inc. (OTC Pink: HEMP) and its affiliated company, One World Pharma SAS.

The LOI outlines a purchase agreement through which Hemp Inc. would purchase CBD Crude and CBD Distillate, non-psychoactive ingredients. Hemp Inc. anticipates the purchase of 3,000 kilograms every 3-4 months. The LOI states that the price per kilo will be based on the prevailing U.S. market price less mutually agreed volume discounts. The LOI sets forth a due diligence period and the shipment of a sample from Colombia to the United States.

“One World Pharma is elated to now be entering our anticipated commercialization phase of our Colombian grown CBD ingredients,” stated Brian Moore, President, One World Pharma. “This opportunity to work with one of the most well-known and well-established hemp companies is an important seminal transaction and clearly our 30% discount to most U.S. CBD pricing was very attractive to Hemp, Inc.”

“Upon finalization of a Definitive Agreement OWP will quickly provide to Hemp Inc. the requisite ingredients and prove an international sales channel for economically grown CBD ingredients from our expansive operations in Colombia,” added Moore.

Information about Forward-Looking Statements

This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, risks related to operating in Colombia, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting One World Pharma, please refer to the Company's Current Report on 8-K/A filed with the Securities and Exchange Commission on July 12, 2019, which is available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

SPRING HOPE, NC, Feb. 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE — Hemp, Inc. (OTC PINK: HEMP) a global leader in the industrial hemp industry with bi-coastal processing centers, including the largest multipurpose industrial hemp processing facility in Spring Hope, NC, a state-of the art local processing center in Southern Oregon, a 500-acre hemp growing Veteran Village Kins Community in Golden Valley, Arizona, two model “Small Family Hemp Farms” in North Carolina and Arizona, and a pre-roll blending manufacturing facility in Las Vegas, NV, announced today that Hemp, Inc.’s wholly owned subsidiary, Industrial Hemp Manufacturing, LLC (IHM), is now fulfilling a $1 million dollar sales agreement for its DrillWall™, their proprietary kenaf-hemp blend natural Loss Circulation Material (LCM) product for the oil and gas well drilling industries.

The Company has executed a sales agreement to sell $1 million worth of DrillWall™ over the course of one year. According to Hemp, Inc. CEO, Bruce Perlowin, IHM received its first $30,000 payment and shipped the first batch of DrillWallTM out about a month ago. Yesterday, another $60,000 payment was received for the second batch of DrillWallTM. “We expect another $90,000 to go out this month and $150,000 to be shipped in March with the balance being shipped throughout the rest of 2020,” said Perlowin. IHM is based in Spring Hope, North Carolina, and is the production facility for DrillWall™, along with other industrial hemp products.

DrillWall™ is a tested LCM made of kenaf and hemp cellulose. It includes milled products from kenaf and hemp that are made into oil drilling fluid additives and oil absorbents. IHM management was key in developing this product years ago for the oil and gas drilling industry, which has had a positive impact on many large projects.

DrillWall™ is insoluble in water, non-toxic, and is a biodegradable drilling fluid additive used in oilfield drilling applications. This product is used by many major oil, water and gas companies. Loss circulation of drilling fluids can have severe impacts on the time, money and safety of any project. The Company’s proprietary LCM product also acts as a borehole stabilizer, a lubricating agent, as well as prevents differential sticking. The proprietary LCM product works faster to plug the leaks and is cost competitive with most LCM materials.

According to a report from Research and Markets, the global industrial hemp market is projected to grow from USD 4.6 billion in 2019 to USD 26.6 billion by 2025, recording a CAGR of 34%.

“We will be consistently distributing Hemp, Inc.’s proprietary Loss Circulation Material over the course of our contract. We are especially excited about the increased interest in DrillWall™. It’s an example of the way hemp is being used for the sake of sustainability and the way Hemp, Inc. is spearheading that movement,” said Hemp, Inc. CEO Bruce Perlowin. “On a cost-performance basis, DrillWall™ is superior to most LCM’s in the marketplace and is the best option for buyers looking for non-toxic alternatives for their operations.” To see the technical specifications of Hemp, Inc.’s DrillWallTM, click here.

“This marks a major change in the direction of the company from building the industrial hemp infrastructure to generating what we expect to be massive revenues by now aggressively focusing on sales and marketing. The shareholders can expect to see upcoming press releases announcing revenues being generated by our 10 divisions. The year 2020 will be a banner year in terms of generating income,” concluded Perlowin.

To see one-minute videos of Hemp, Inc.’s current activities, visit Bruce Perlowin’s personal Facebook page, where he shares daily posts of Hemp, Inc.’s activities around the country. For more info on DrillWall™ click here and here. Those interested in this product can contact Sandra Williams, IHM’s Plant Manager, at swilliams@hempinc.com.

PLEASE NOTE: The following information has been updated to reflect Hemp, Inc.’s current state of affairs.

I suspect in the end this years crop will be auctioned off for next to nothing just to garner a few bucks--but as a go forward--forget it.

Spring Hope, NC, Jan. 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Hemp, Inc. (OTC PINK: HEMP) a global leader in the industrial hemp industry with bi-coastal processing centers, including the largest multipurpose industrial hemp processing facility in the western hemisphere in Spring Hope, North Carolina, announced today news coverage in revered industry podcast, Pot.Live, a podcast series dedicated to the latest news and trends in the cannabis industry coming from the industry's thought leaders. Guests speak on how they made their cannabis businesses successful, the lessons they have learned and what they see for the future of the cannabis industry.

The podcast interview features a conversation between Pot.Live podcast host Len Giancola and Bruce Perlowin, CEO of Hemp, Inc. During the interview Perlowin discusses the evolution of the business, Hemp Inc.'s innovative products such as the Company’s kenaf products, DrillWall™ and Spill-Be-Gone™, its hemp pre-rolls, and hemp bioplastics.

“To be able to be part of the supply chain to make bioplastics -- I actually consider myself to be one of my own heroes now,” said Bruce Perlowin, CEO of Hemp, Inc., during the podcast interview. “I’m actually doing something on a large scale that’s going to change the world and bring hemp bioplastics into the environment.”

The interview also delves into Perlowin’s personal history of becoming the "King of Pot", his smuggling experiences and imprisonment. Additionally, the podcast episode provides a general overview of the cannabis industry, taxation and the black market, Hemp, Inc.’s Eco Village initiative (the hemp growing Veteran Village Kins Community in Golden Valley, AZ) and whether business ought to go public or stay private.

According to a June 2019 market research report published by MarketsandMarkets™, the industrial hemp market is projected to grow from $4.6 billion in 2019 to $26.6 billion by 2025, recording a compound annual growth rate of 34.0% during the forecast period.

“Speaking on Hemp, Inc.’s breadth of initiatives and accomplishments with Len on the Pot.Live Podcast was incredibly important for The Company because it allows for our message to be shared with a new audience,” said Perlowin. “I was able to speak on what I am passionate about and how that translates to Hemp, Inc.’s activities as a business and leader in the hemp industry.”

Las Vegas, NV, Jan. 08, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Hemp, Inc. (OTC PINK: HEMP) a global leader in the industrial hemp industry with bi-coastal processing centers, has announced that approximately 33,000 pounds of hemp biomass have been processed and are now available for sale.

The biomass that is available for sale tested at a minimum of 7.5% cannabidiol (CBD). The biomass is from Pre-98 OG Bubba Kush, one of the top selling cultivars on the market. According to a report from Research and Markets, the global industrial hemp market is projected to grow from USD 4.6 billion in 2019 to USD 26.6 billion by 2025, recording a CAGR of 34%.

Hemp, Inc. announced Nov. 21, 2019 that it had accomplished two harvests and the drying of its A and B buds from the same strain. The strain, rich soil, and climate lend themselves to Hemp, Inc. colas being among the highest quality buds, positioning them to be some of the best tasting for consumption.

The A and B colas will be used to fill Hemp, Inc.’s “King of Hemp™” pre-rolls, a product line that offers high-end products that are an effective and flavorful alternative to cigarettes and other hemp consumption methods. The pre-rolls are compliant with federal regulations and do not exceed 0.3% THC. Samples of the finished product have recently hit the marketplace.

Hemp, Inc. identified an increased demand for smokable hemp flower as people seek more effective methods of consumption. The Brightfield Group predicts the smokable hemp flower market is projected to be worth $70.6 million this year, jumping from $11.7 million in 2018.

“The hemp biomass comes from the hemp plants that produced the A and B colas for the King of Hemp™ product line, meaning that the biomass comes from the highest quality hemp plants,” said Hemp, Inc. CEO Bruce Perlowin. “It’s really remarkable that we are able to offer biomass for sale and industrial use, and speaks to the versatility of the hemp plant.”

To see one-minute videos of Hemp, Inc.’s current activities, visit Bruce Perlowin’s personal Facebook page, where he shares daily posts of Hemp, Inc.’s activities around the country. Those interested in purchasing Hemp, Inc.’s pre-rolls should email flower@hempinc.com.

The published news broadcast segment entitled, “Hemp farmers in red tape,” features an interview with Barry Epling, CEO of Farming Capital Corp, a wholly-owned subsidiary of Hemp, Inc.

a global leader in the industrial hemp industry with bi-coastal processing centers, announced today news coverage in local news outlet KTVL (CBS) based out of Medford, Oregon, and the Smoky Mountain News.

The published news broadcast segment entitled, “Hemp farmers in red tape,” features an interview with Barry Epling, CEO of Farming Capital Corp, a wholly-owned subsidiary of Hemp, Inc. The coverage includes footage from Hemp, Inc.’s state-of-the-art hemp processing facility as the Company works through harvest season in Rogue Valley and Epling’s commentary on the USDA’s proposed regulations for hemp.

While Hemp Inc. is compliant with regulations, Epling discusses why he thinks the currently proposed regulation with a total THC limit would severely damage the hemp industry. Epling explains that testing should be limited to delta-9 THC as reflected in the Farm Bill, not the entire spectrum of THC content. Epling’s quote from the segment states, “You now have a bureaucrat who is not elected in some organization saying I'm going to override the federal government, and I'm going to rewrite the farm bill. I think it's very arrogant, I don't think they have a right to do it, and I hope the courts can put an end to that."

The Smoky Mountain News article titled, “Legislature to ban smokable hemp in N.C.” reports on how North Carolina legislators are making efforts to ban smokable hemp, as it is difficult for law enforcement to distinguish marijuana from hemp.

The article features commentary from Bruce Perlowin, CEO of Hemp Inc., wherein he discusses how the idea of moving forward with uniform regulations is good in principle for safety and quality control.

His quote from the article states, “From lifting the ban to the first harvest in 80 years, we will now gain clarity on an array of hemp-specific policies such as safety and quality control standards. Growers, especially small farmers, will benefit from the expansion of crop insurance, standards and infrastructure that can be built out based on the sheer certainty that comes with uniform regulations. We’ve also been working to educate law enforcement. They are frustrated and we get it. We’re trying to satisfy their concerns but what they need is a reliable, mobile field test and that’s not there yet.”

According to a June 2019 market research report published by MarketsandMarkets™, the industrial hemp market is projected to grow from $4.6 billion in 2019 to $26.6 billion by 2025, recording a compound annual growth rate of 34.0% during the forecast period.

“From the topics of the stories we have been covered in, it is apparent that more uniform education on the plant and its farmers must take place in order for uniform regulation to truly benefit the industry as intended,” Perlowin said.

To watch the KTVL broadcast segment, click here. To read the full published article, click here.

To provide clarification on a release sent on Nov. 6, 2019 titled “Hemp, Inc. Oregon Processing Operation Featured in NewsWatch 12's Harvest Coverage,” Barry Epling is the CEO of Farming Capital Corp, a wholly-owned subsidiary of Hemp, Inc. Bruce Perlowin is the CEO of Hemp, Inc.

The published news segment features an interview with Barry Epling, CEO of Hemp, Inc. wholly-owned subsidiary Farming Capital Corp.